We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Program Evaluation of People With Arthritis Can Exercise

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00153309
First Posted: September 12, 2005
Last Update Posted: December 9, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
University of Missouri-Columbia
St. Louis University
Information provided by:
Centers for Disease Control and Prevention
September 7, 2005
September 12, 2005
December 9, 2005
June 2003
Not Provided
  • Physical Activity Level - PASE instrument at baseline, 8 and 16 weeks.
  • Pain Visual Analog Scale - at baseline, 8 and 16 weeks
  • Physical Function using the Functional Fitness Battery at baseline, 8 and 16 weeks
  • Self-reported function (HAQ) at baseline, 8 and 16 weeks
Same as current
Complete list of historical versions of study NCT00153309 on ClinicalTrials.gov Archive Site
  • Health-related quality of life
  • Disease status
  • Self-efficacy for arthritis management
  • Self-efficacy for exercise
  • Social support
  • Depressive symptoms
  • Anxiety
Same as current
Not Provided
Not Provided
 
Program Evaluation of People With Arthritis Can Exercise
Evaluation of the Health Benefits of the People With Arthritis Can Exercise Program
The purpose of this study is to evaluate the health and arthritis-specific benefits of participation in the Arthritis Foundation People with Arthritis Can Exercise program and to collect information to improve community-based dissemination of this program.

Only about 24% of people with arthritis report sufficient physical activity to provide general health benefits. Research has demonstrated that many people with arthritis can safely exercise to improve fitness and health. The People with Arthritis Can Exercise (PACE) program, developed by the Arthritis Foundation, is a land-based recreational physical activity and exercise program. PACE has been offered as a community-based program for over 10 years and small studies have reported benefits for people with arthritis. However, there has been no randomized controlled community trials that evaluate the effectiveness of PACE in the community. The goals of the Evaluation of PACE project are to: (1) appropriately evaluate the AF PACE exercise program, and (2) provide information to support effective content, recruitment and programming. Specific objectives for meeting these goals include:

  1. Identify the theoretical foundations and constructs for evaluating the program and select and use appropriate outcome measures;
  2. Plan and conduct a randomized controlled trial of 8 and 16 week PACE programs;
  3. Perform a qualitative evaluation using focus groups of PACE instructors and participants;
  4. Disseminate findings and make recommendations.
Interventional
Phase 2
Phase 3
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Arthritis
  • Osteoarthritis
  • Rheumatoid Arthritis
Behavioral: People with Arthritis Can Exercise
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
320
June 2005
Not Provided

Inclusion Criteria:

  • Adults age 18 and older
  • Self-reported arthritis or chronic joint symptoms
  • Community-dwelling

Exclusion Criteria:

  • Serious medical conditions which would contraindicate exercise
  • No severe physical or mental condition
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00153309
CDC-NCCDPHP-0507
CDC-NCCDPHP-MM-0507
Not Provided
Not Provided
Not Provided
Not Provided
Centers for Disease Control and Prevention
  • University of Missouri-Columbia
  • St. Louis University
Study Director: Jennifer M Hootman, PhD Centers for Disease Control and Prevention
Principal Investigator: Marian Minor, PhD University of Missouri-Columbia
Centers for Disease Control and Prevention
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP